Home Capital Broker's Calls

Analysts upbeat on CRCT acquiring five business parks, retail mall

Jeffrey Tan
Jeffrey Tan11/11/2020 02:00 PM GMT+08  • 2 min read
Analysts upbeat on CRCT acquiring five business parks, retail mall
DBS believes that the acquisition will bring stability and future-proof its earnings profile against future pandemics.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts are positive on CapitaLand Retail China Trust’s (CRCT) proposed $1 billion acquisition of five business parks and the remainder 49% stake in Rock Square mall.

This comes after CRCT recently expanded its mandate to cover multi-assets used primarily for retail, office and industrial use.

The proposed acquisition will be financed through a mix of debt, equity, perpetual securities and internal cash resources.

OCBC Investment Research says the proposed acquisition is expected to be distribution per unit (DPU) accretive with pro-forma FY19/1HFY20 DPU increasing 2.8% and 5.1%, respectively.

“The proposed acquisition will pave the way to enhance CRCT’s long-term resilience and diversification,” OCBC analyst Chu Peng writes in a note dated Nov 9.

UBS Securities says the net property income yield and DPU accretion was a positive surprise.

The brokerage reckons that a $300m potential equity raising is “digestible”, while the use of perpetual securities would keep gearing in check.

For more stories about where the money flows, click here for our Capital section

“Execution is crucial to improve investor confidence and funding cost,” UBS analysts Kok Wai Fai and Michael Lim write in a Nov 6 report.

Meanwhile, DBS Group Research says CRCT could potentially grow its portfolio by more than tenfold.

“With an expanded investable universe which will include business parks, commercial, data centres and logistics, we believe that acquisitions in these asset classes will bring stability and future-proof its earnings profile against future pandemics,” DBS analysts Geraldine Wong and Derek Tan write in a note dated Nov 6.

OCBC, UBS and DBS have maintained their “buy” rating for CRCT with an unchanged fair value of $1.35 and target price of $1.35 and $1.55, respectively.

As at 1.55 pm, CRCT was up 2 cents or 1.6% at $1.28 with 9.2 million units changed hands.

See Also: CapitaLand to divest interest in 5 business park properties and Rock Square mall to CapitaLand Retail China Trust

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.